Pao Jiang

Zingiber officinale Roscoe

Also known as: Blast-fried ginger(English) Carbonized ginger(English) 炮姜(Chinese)

P'ao Chiang

Updated October 5, 2026 · Not yet clinically reviewed

Pao Jiang
Köhler's Medizinal-Pflanzen, 1500 · public domain, via Wikimedia Commons

Safety at a glance

Caution

With warfarin, coumadin, phenprocoumon: probable potentiation: INR rise and bleeding in case reports and a cohort; no effect in healthy volunteers

Note

3 recorded drug interactions

Note

Contraindications or side effects are listed

No rule in our tables for this herb: pregnancy, breastfeeding, incompatible pairs (十八反 / 十九畏), dose ceiling. This is not a safety clearance.
Not graded —

No toxicity grade is recorded. Most herbs in the catalogue carry none.

Traditional Chinese Medicine

Category
regulating blood
Temperature
Hot
Taste
Pungent,Bitter
Channels
Spleen,Liver,Kidney

Traditional uses

Pao Jiang is dried ginger rhizome (Zingiber officinale) that has been blast-fried or charred until puffed and brown-black. This processing makes it bitter and astringent and warm (rather than hot), with its action shifting to the Spleen and Liver channels. It loses the strong interior-warming and Yang-rescuing power of Gan Jiang but gains a marked ability to warm the channels and stop bleeding, and to warm the middle and relieve pain.

It is used chiefly for Cold- and deficiency-type bleeding, especially uterine bleeding, prolonged post-partum lochia, and blood in the stool with Cold signs (pale blood, cold limbs, weak pulse), and for cold, cramping abdominal pain and chronic Cold diarrhea. Classic pairings include Pao Jiang with Ai Ye and Dang Gui. It is contraindicated in Heat patterns and used cautiously in pregnancy.

Western herbalism

Properties: carminative, stimulant

Formulas using this herb

7 of 7 formulas

Botanical

Pao Jiang is a processed form of the rhizome of Zingiber officinale Roscoe (ginger), a perennial herbaceous plant in the Zingiberaceae cultivated throughout tropical and subtropical Asia. The aerial shoots are 0.6-1.2 m tall, with two-ranked, linear-lanceolate leaves 15-30 cm long arising from sheathing pseudostems. Inflorescences are dense cone-like spikes borne on separate short stalks from the rhizome, with pale yellow flowers marked purple. The medicinal organ is the underground branched, sympodial rhizome, pale buff externally and pale yellow internally, with a pungent aromatic odour. For Pao Jiang ("blast-fried ginger"), the dried mature rhizome (Gan Jiang) is dry-fried over high heat in sand or directly in a hot wok until the outer surface is uniformly scorched brownish-black and the interior is yellow-brown.

Family
Zingiberaceae
Parts used
rhizome
Plant type
herb

Constituents

6-Shogaol

Vanillyl ketone (phenylalkanone) · present only in traces in the fresh rhizome; the dominant pungent principle after high-temperature processing, rising as gingerols dehydrate

6-Shogaol is the dehydration product of 6-gingerol and is formed preferentially when ginger is dried or heated, so blast-fried (pao) ginger is relatively shogaol-rich compared with fresh ginger. It is anti-inflammatory and antioxidant in cell models and is generally regarded as the more pungent and more warming of the two.

6-Gingerol

Vanillyl ketone (phenylalkanone) · the principal pungent constituent of the fresh and simply dried rhizome; substantially depleted by stir-frying and by carbonisation

6-Gingerol accounts for much of raw ginger's pungency and for its in vitro inhibition of cyclooxygenase and of arachidonic-acid-induced platelet aggregation. Because blast-frying converts it to 6-shogaol, the processed drug carries less of it than raw or plain dried ginger.

Zingerone

Vanillyl ketone (methoxyphenol) · a thermal degradation product; increases with drying and frying temperature

Zingerone arises from retro-aldol cleavage of gingerols during heating and contributes the sweeter, less biting flavour of cooked and processed ginger. It is one of the five markers used to distinguish fresh, dried, stir-fried and carbonised ginger analytically.

Total phenolics of the processed rhizome

Phenolic compounds (mixed) · highest in plain dried ginger; roughly 2.4-fold lower in carbonised ginger than in dried ginger

Processing systematically lowers extractable phenolic content, and antioxidant activity tracks it in the order dried > stir-fried > fresh > carbonised. This is the measurable chemical basis for treating pao jiang as a different drug from gan jiang rather than a milder version of it.

Carbonised-ginger carbon dots (CG-CDs)

Carbonaceous nanoparticles · isolated from the aqueous extract of high-temperature-processed ginger; mean particle diameter about 4.07 nm

Nanoparticles formed during carbonisation, absent from the unprocessed herb. In rodent bleeding models they shortened bleeding time and clotting time, raised fibrinogen and TXB2 and lowered t-PA and 6-keto-PGF1alpha, which is the first mechanistic account offered for why charred ginger is used as a haemostatic when raw ginger is not.

Drug interactions

Warfarin

Moderate · Possible increase in INR and bleeding risk; not reproduced in controlled dosing studies · Evidence level: Possible

Ginger constituents inhibit cyclooxygenase and arachidonic-acid-induced platelet aggregation in vitro, giving a pharmacodynamic rationale for additive bleeding risk. However, an open-label three-way crossover study in 12 healthy men found that ginger at recommended doses did not alter the pharmacokinetics or pharmacodynamics of a 25 mg warfarin dose, did not change S-warfarin or R-warfarin protein binding or volume of distribution, and did not change CYP2C9 activity as measured by S-7-hydroxywarfarin urinary excretion. A 2017 systematic review reached the same conclusion. The signal rests on isolated case reports of raised INR, including one with phenprocoumon.

Clinical note: Do not withhold pao jiang on this basis alone, but check INR when starting or stopping it in an anticoagulated patient, and treat any unexplained INR rise as potentially herb-related.

Antiplatelet agents (aspirin, clopidogrel)

Minor · Theoretical additive antiplatelet effect; human data conflicting · Evidence level: Possible

A systematic review of 10 human studies (8 clinical trials, 2 observational) found the evidence that ginger affects platelet aggregation to be equivocal: four trials showed reduced aggregation and four showed none. Effects, where seen, clustered at higher doses (5 g and above), well above the 3-9 g/day of decocted pao jiang and far above the doses used for nausea.

Clinical note: No routine restriction at normal decoction doses. Advise patients on dual antiplatelet therapy to report unusual bruising if taking large or prolonged doses.

CYP2C9 and CYP3A4 substrates

Theoretical · Predicted increase in substrate exposure; not observed clinically · Evidence level: Theoretical

Ginger extract and isolated 6-gingerol inhibit CYP2C9 and CYP3A4 in microsomal assays at micromolar concentrations, and molecular modelling of ginger constituents predicts inhibition of CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A4. Controlled human probe studies with warfarin (CYP2C9) have not shown a corresponding change in metabolism, so the in vitro finding has not translated.

Clinical note: No dose adjustment is warranted on current evidence. Note that pao jiang is shogaol- rather than gingerol-dominant, so the in vitro data on 6-gingerol may not even describe the processed drug.

Dosage

FormAmountFrequencyNotes
decoction3–9 gDaily
中国药典 2020 【用法与用量】3~9g。 【性味与归经】辛,热。归脾、胃、肾经。 — Chinese Pharmacopoeia 2020, quoted verbatim; route and cautions preserved. Replaces a cleared category-filler value.

Evidence

Study design on record, not certainty of outcome.

Randomized controlled trial
1
Observational / case report
1
In vitro / animal
2

Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects

Jiang X, Williams KM, Liauw WS, et al. · British Journal of Clinical Pharmacology · 2005 · RCT

Randomized controlled trial · Verified

Open-label, three-way crossover randomised study in 12 healthy male subjects given a single 25 mg dose of warfarin alone or after 7 days of pretreatment with recommended doses of ginkgo or ginger. Neither herb affected clotting status, warfarin pharmacokinetics or pharmacodynamics; the S-7-hydroxywarfarin urinary excretion rate ratio for ginger was 1.00 (0.81-1.23), indicating no effect on CYP2C9.

doi:10.1111/j.1365-2125.2005.02322.x

The Effect of Ginger (Zingiber officinale) on Platelet Aggregation: A Systematic Literature Review

Marx W, McKavanagh D, McCarthy AL, Bird R, Ried K, Chan A, Isenring L · PLOS ONE · 2015 · systematic review

Observational / case report · Verified

Ten human studies (8 clinical trials, 2 observational) were reviewed. Four trials found ginger reduced platelet aggregation and four found no effect, with the observational data equally split. The authors concluded the evidence is equivocal; effects clustered at doses of 5 g or more.

doi:10.1371/journal.pone.0141119

Carbon dots derived from Zingiber officinale Rosc (ginger) with hemostatic effects

Hu WJ, Yu AQ, Bi HZ, Zhang ZJ, Wang ZB, Wang M, Kuang HX · Frontiers in Molecular Biosciences · 2025 · animal

In vitro / animal · Not yet verified

Carbon dots were extracted from the aqueous solution of carbonised ginger and characterised at about 4.07 nm. In mouse tail-bleeding and liver-injury bleeding models plus capillary coagulation assays they shortened bleeding time, reduced blood loss and shortened clotting time, with raised fibrinogen and TXB2 and lowered t-PA and 6-keto-PGF1alpha. This is preclinical and directly addresses the processed drug rather than raw ginger.

doi:10.3389/fmolb.2025.1530469

Chemical characterization and antioxidant activities comparison in fresh, dried, stir-frying and carbonized ginger

Li Y, Hong Y, Han Y, Wang Y, Xia L · Journal of Chromatography B · 2016 · in vitro

In vitro / animal · Not yet verified

UPLC/QTOF-MS identified 27 compounds across fresh, dried, stir-fried and carbonised ginger, and UPLC-PDA quantified zingerone, 6-gingerol, 8-gingerol, 6-shogaol and 10-gingerol. Antioxidant activity ranked dried > stir-fried > fresh > carbonised, with dried ginger's phenolic content 5.2-, 1.1- and 2.4-fold that of fresh, stir-fried and carbonised ginger. Confirms that pao jiang is chemically a distinct drug from gan jiang.

doi:10.1016/j.jchromb.2016.01.009

Safety

Contraindications

Its use is prohibited in pregnant women and patients with yin deficiency and fever.

Source: Xi S, Gong Y. Essentials of Chinese Materia Medica and Medical Formulas. Academic Press/Elsevier, 2017, pp. 225–226.

Cultural and historical

Shen Nong Ben Cao Jing · Han dynasty

Records gan jiang (dried ginger) for fullness in the chest, cough with counterflow qi, warming the centre and stopping bleeding (wen zhong zhi xue), promoting sweating, expelling wind-damp impediment, and for dysenteric disorder. The haemostatic indication that pao jiang is now used for is already present in this earliest entry, though the classic describes dried, not blast-fried, ginger.

Lei Gong Pao Zhi Lun · Northern and Southern dynasties (c. 500 CE)

The first text devoted to pao zhi (medicinal processing); ginger processing first appears here, which is the earliest documentary basis for treating blast-fried ginger as a drug separate from the dried rhizome.

Ben Cao Gang Mu · Ming dynasty

Systematises processing into water, fire, combined water-and-fire and fermentation categories, within which the fire-processing of ginger to yield pao jiang is placed. The clinical maxim distinguishing the three forms - fresh ginger moves and does not guard, dried ginger both moves and guards, blast-fried ginger guards and does not move - reflects this literature.

References

  1. Chen Z, Ye SY, Yang Y, Li ZY. A review on charred traditional Chinese herbs: carbonization to yield a haemostatic effect. Pharmaceutical Biology. 2019 doi:10.1080/13880209.2019.1645700
  2. Choi S, Oh DS, Jerng UM. A systematic review of the pharmacokinetic and pharmacodynamic interactions of herbal medicine with warfarin. PLOS ONE. 2017 doi:10.1371/journal.pone.0182794
© Verscienta Health — use subject to the API terms at https://verscienta.com/developers/api; educational reference, not medical advice